UnknownNot Applicable

Evaluation of Blastocyst Morphology and Quality in Patients With Embryo Transfer at the Blastocyst Stage

Turkey (Türkiye)500 participantsStarted 2022-05-01

Plain-language summary

In this prospective study, the investigators aim to investigate the role of trophectoderm cells and inner cell mass cells on pregnancy outcomes in blastocyst transferred in-vitro fertilization pregnancy. The investigators will support findings with bilateral uterine artery Doppler measurements to be made between the 11th and 14th weeks of pregnancy.

Who can participate

Age range18 Years – 40 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Exogenous hormone preparation of the endometrial lining * Single embryo transfer * Embryo transfer at the blastocyst stage Exclusion Criteria: * Double embryo transfer * Patients who underwent embryo transfer at the cleavage stage * \>15% loss of embryo viability during embryo thawing * Patients whose data could not be accessed after follow-up or delivery

What they're measuring

Live Birth Rate

Timeframe: 9 months

Obstetric Complication Rates

Timeframe: 20 weeks after embryo transfer

Trial details

NCT IDNCT05510557

SponsorAkdeniz University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-07-31

Contact for this trial

Şafak Olgan, MD

+905064068740 safakolgan@gmail.com

View on ClinicalTrials.gov More Infertility trials